For Scientists >
Molecular Neurodegeneration Journal
BrightFocus Foundation
Molecular Neurodegeneration Journal

Molecular Neurodegeneration (MN) is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular, cellular, and system levels. MN, the official journal of BrightFocus Foundation, focuses on neurodegenerative disease research, including but not limited to, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and glaucoma.
Molecular Neurodegeneration is the No. 1 open-access peer-reviewed neuroscience journal.
The growth in scientific impact and reputation is reflected in the following metrics:
- Impact factor: 17.5 in 2024, up 17.5% from 2023’s impact factor of 14.9
- 15.1 in 2022, 14.9 in 2023
- Journal usage: There were 1,877,858 article downloads in 2024, according to Springer Nature.
- 1,584,169 downloads in 2023 and 1,213,867 article downloads in 2022
- Citations tracked by Web of Science: 11,410 in 2024 (up 16% from 2023).
- Molecular Neurodegeneration has been ranked as the No. 1 open-access journal in the neuroscience category for 12 years in a row (2013 – present), and is currently ranked No. 4 among all 314 neuroscience journals.